198 related articles for article (PubMed ID: 38170440)
1. Guggulsterone Selectively Modulates STAT-3, mTOR, and PPAR-Gamma Signaling in a Methylmercury-Exposed Experimental Neurotoxicity: Evidence from CSF, Blood Plasma, and Brain Samples.
Kumar S; Mehan S; Khan Z; Das Gupta G; Narula AS
Mol Neurobiol; 2024 Jan; ():. PubMed ID: 38170440
[TBL] [Abstract][Full Text] [Related]
2. Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain.
Kumar N; Sharma N; Khera R; Gupta R; Mehan S
Metab Brain Dis; 2021 Jun; 36(5):911-925. PubMed ID: 33635478
[TBL] [Abstract][Full Text] [Related]
3. Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity.
Shandilya A; Mehan S; Kumar S; Sethi P; Narula AS; Alshammari A; Alharbi M; Alasmari AF
Molecules; 2022 Jun; 27(12):. PubMed ID: 35745001
[TBL] [Abstract][Full Text] [Related]
4. Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS.
Minj E; Upadhayay S; Mehan S
Neurochem Res; 2021 Nov; 46(11):2867-2884. PubMed ID: 34075522
[TBL] [Abstract][Full Text] [Related]
5. Icariin prevents methylmercury-induced experimental neurotoxicity: Evidence from cerebrospinal fluid, blood plasma, brain samples, and in-silico investigations.
Sharma S; Mehan S; Khan Z; Gupta GD; Narula AS
Heliyon; 2024 Jan; 10(1):e24050. PubMed ID: 38226245
[TBL] [Abstract][Full Text] [Related]
6. Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism.
Khera R; Mehan S; Bhalla S; Kumar S; Alshammari A; Alharbi M; Sadhu SS
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164154
[TBL] [Abstract][Full Text] [Related]
7. Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats.
Sahu R; Mehan S; Kumar S; Prajapati A; Alshammari A; Alharbi M; Assiri MA; Narula AS
Toxicol Rep; 2022; 9():977-998. PubMed ID: 35783250
[TBL] [Abstract][Full Text] [Related]
8. Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations.
Chhabra S; Mehan S; Khan Z; Gupta GD; Narula AS
J Neuroimmunol; 2023 Nov; 384():578200. PubMed ID: 37774554
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of apigenin on methylmercury-induced behavioral/neurochemical abnormalities and neurotoxicity in rats.
Yadav RK; Mehan S; Sahu R; Kumar S; Khan A; Makeen HA; Al Bratty M
Hum Exp Toxicol; 2022; 41():9603271221084276. PubMed ID: 35373622
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions.
Kumar S; Mehan S; Narula AS
J Mol Med (Berl); 2023 Feb; 101(1-2):9-49. PubMed ID: 36478124
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's Disease.
Kiaei M
PPAR Res; 2008; 2008():418765. PubMed ID: 18464922
[TBL] [Abstract][Full Text] [Related]
12. Acute neurotoxicant exposure induces hyperexcitability in mouse lumbar spinal motor neurons.
Sceniak MP; Spitsbergen JB; Sabo SL; Yuan Y; Atchison WD
J Neurophysiol; 2020 Apr; 123(4):1448-1459. PubMed ID: 32159428
[TBL] [Abstract][Full Text] [Related]
13. Forskolin, an Adenylcyclase/cAMP/CREB Signaling Activator Restoring Myelin-Associated Oligodendrocyte Destruction in Experimental Ethidium Bromide Model of Multiple Sclerosis.
Kapoor T; Mehan S; Suri M; Sharma N; Kumar N; Narula AS; Alshammari A; Alasmari AF; Alharbi M; Assiri MA; Kalfin R
Cells; 2022 Sep; 11(18):. PubMed ID: 36139346
[TBL] [Abstract][Full Text] [Related]
14. Role of JAK-STAT and PPAR-Gamma Signalling Modulators in the Prevention of Autism and Neurological Dysfunctions.
Khera R; Mehan S; Kumar S; Sethi P; Bhalla S; Prajapati A
Mol Neurobiol; 2022 Jun; 59(6):3888-3912. PubMed ID: 35437700
[TBL] [Abstract][Full Text] [Related]
15. Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination.
Defaux A; Zurich MG; Braissant O; Honegger P; Monnet-Tschudi F
J Neuroinflammation; 2009 May; 6():15. PubMed ID: 19422681
[TBL] [Abstract][Full Text] [Related]
16. The peroxisome proliferator-activated receptor γ (PPARγ) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis.
Benedusi V; Martorana F; Brambilla L; Maggi A; Rossi D
J Biol Chem; 2012 Oct; 287(43):35899-911. PubMed ID: 22910911
[TBL] [Abstract][Full Text] [Related]
17. Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis.
Lecarpentier Y; Vallée A
Front Neurol; 2016; 7():100. PubMed ID: 27445967
[TBL] [Abstract][Full Text] [Related]
18. Dysfunction of the oligodendrocytes in amyotrophic lateral sclerosis.
Gong Z; Ba L; Zhang M
J Biomed Res; 2022 Aug; 36(5):336-342. PubMed ID: 36106501
[TBL] [Abstract][Full Text] [Related]
19. Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis.
Lorente Pons A; Higginbottom A; Cooper-Knock J; Alrafiah A; Alofi E; Kirby J; Shaw PJ; Wood JD; Highley JR
J Pathol; 2020 Jul; 251(3):262-271. PubMed ID: 32391572
[TBL] [Abstract][Full Text] [Related]
20. Connection between JAK/STAT and PPARγ Signaling During the Progression of Multiple Sclerosis: Insights into the Modulation of T-Cells and Immune Responses in the Brain.
Kumar N; Sharma N; Mehan S
Curr Mol Pharmacol; 2021; 14(5):823-837. PubMed ID: 33645493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
